NBIX Neurocrine Biosciences, Inc. logo

NBIX Neurocrine Biosciences, Inc.

Healthcare
$155.73-0.62%ClosedMarket Cap: $15.66B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

11

Dispositions

14

Buy/Sell Ratio

0.79

Net Shares

-263,898

Shares Acquired

244,973

Shares Disposed

508,871

Total Bought ($)

$0.00

Total Sold ($)

$3.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu May 21SHERWIN STEPHEN AdirectorSell3,318$0.0015,860
Thu May 21Sharp ShalinidirectorSell1,659$0.004,088
Thu May 21RASTETTER WILLIAM HdirectorSell3,318$0.0043,678
Thu May 21POPS RICHARD FdirectorSell3,318$0.0037,798
Thu May 21POON CHRISTINE AdirectorSell3,318$0.004,753
Mon May 18POPS RICHARD FdirectorSell15,000$157.6534,480
Mon May 18POPS RICHARD FdirectorSell15,000$47.8949,480
Thu May 14Norwalk Leslie VdirectorSell3,810$155.012,429
Tue Mar 17Ratz Andrewofficer: Chief Technical Operations OffSell31,348$124.120
Tue Mar 17Ratz Andrewofficer: Chief Technical Operations OffSell17,724$150.100
Tue Mar 17Ratz Andrewofficer: Chief Technical Operations OffSell5,640$0.000
Tue Mar 17Ratz Andrewofficer: Chief Technical Operations OffSell2,664$150.100
Tue Mar 17Ratz Andrewofficer: Chief Technical Operations OffSell805$124.120
Tue Mar 17Ratz Andrewofficer: Chief Technical Operations OffSell0$0.001,018
Thu Mar 05ABERNETHY MATTofficer: Chief Financial OfficerSell2,249$0.0042,808